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The acetylation of 4-methoxy and 4,9-dimethoxy-7-methyl-5H-furo-[3,2-g] [1] benzopyran-c-one
(visnagin and khellin) 1 a-b with acetic anhydride gives 3-acetyl-visnagin and khellin 2a-b which on
reaction with cyanoacetamide, a-cyanothioacetamide, malononitriles or ethyl cyanoacetate yield
furobenzopyranyl pyridone derivatives 3 a-h or the possible isomer 4 a-h. When 3-acetyl-visnagin or
khellin is treated with bromine 6-(ro-bromoacetyl) visnagin or khellin 5 a-b is obtained. The latter
compound on treatment with thiourea and amines forms the 2-substituted-4-(3-furobenzopyranyl)
thiazole 6 a-b and 6-(ro-aminoacetyl) furochromone derivatives 8 a-g respectively. The 2-amino-4-(3-
furobenzopyranyl) thiazole on condensation with aldehyde yields the iminosubstituted thiazole
derivatives 7 a-e. Results of the biological effect of compounds la, 6b, 3a, 8a and 3d on blood pressure
in experimental animals have been reported.
Benzopyran derivatives are known to have wide
variety of pharmacological activities!". This
prompted us to modify this ring and to explore new
activities associated with this nucleus. Herein we
report the synthesis and biological activity of
hitherto unknown derivatives of 3-acetyl-visnagin
and khellin.
When 4-methoxy-7-methyl-5H-furo[3,2-g][l]
benzopyran-5-one la (visnagin) or 4,9-dimethoxy-
7-methyl-5H-furo[3,2-g][ 1] benzopyran-5-one lb
(khellin) was refluxed with acetic anhydride, 6-
acetyl-visnagin 2a and khellin 2b respectively
were obtained (cf. Table I). Compounds 2a-b
separately on reaction with cyanoacetamide, cc-
cyanothioacetamide, malononitrile and ethyl
cyanoacetate in the presence of ammonium acetate
yielded furochromones 3a-h or the possible
isomers 4a-h respectively (cf. Table I).
Bromination of 6-acetyl-visnagin 2a and 6-acetyl-
khellin 2b with bromine in chloroform yielded 6-
(co-bromoacetyl)visnagin and khellin 5a-b6
respectively (Scheme I, cf. Table I). Further, 5a-b
on treatment with thiourea and amines (i.e.
benzyl amine, p-aminobenzoic acid, p-toluidine or
morpholine) in ethanol yielded the compounds 6a-
band 8a-g respectively (cf. Table I). When 6a-b
were condensed with the appropriate aldehyde (i.e.
benzaldehyde, 4-chlorobenzaldehyde or p-N,N-
dimethylaminobenzaldehyde) iminosubstituted thi-
azole derivatives 7a-e were obtained (cf. Table I).
Analytical and spectroscopic results for all the
compounds were in conformity with the assigned
structures.
Biological activity
Blood pressure recording procedure. Under
general anaesthesia induced by pentobarbitone (40
mg/kg i.p.) blood pressure in rats was recorded
through canula inserted in the carotid artery. After
freshly prepared drugs in gradually increasing
doses were injected into jugular vein through a
polyethylene canula. Compounds la, 6b, 3a, 8a
and 3d were screened for their effects on blood
pressure.
Results and conclusions
Compounds la, 6b and 8a produced dose
dependent drop in blood pressure. The lowering
effect on blood pressure of the three compounds
was of short duration.
As regards compound 3a, in a dose of 1 mg, it
produced a drop of blood pressure and in a dose of
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2mg it produced a biphasic response, at first drop
and then rise in blood pressure followed by return
to the basal value, while in a dose of 4mg/kg it
produced a triphasic response at first drop then rise
and lastly a gradual and persistent decrease in
blood pressure till it ended with shock and death of
animal. Compound 3d produced prolonged drop in
blood pressure, an effect which was lethal after
injecting 4mg/kg. From these results, it can be
concluded that compound la has a potent
depressing but :r:eversible effect on blood pressure.
Compounds 3a and 3d have both potent and lethal
depressing effect on blood pressure and this may
be attributed to the presence of cyano group in 3n
and thione group in 3d. This observation might
throw light on the harmful effect of cyano and
thione groups on blood pressure. On the other hand
the moderate hypotensive effect of compounds 6b
and Sa may be due to the presence of amino group.
Although it is early to say much, these results are
encouraging to investigate the effect of these
compounds on other organs and systems.
Experimental Section
All melting points are uncorrected. The JR
Scheme I
spectra were run in KBr on a Pye-Unicam spllOOO
spectrophotometer. IH NMR spectra in CDCl3 or
DMSO-d 6 on a Varian IM-3901 spectrometer at
90, 200 or 270 MHz using TMS as internal
standard (chemical shifts in 8, ppm) and mass
spectra on a Varian Mat CH-4B spectrometer.
3-Acetyl-visnagin or khellin 2 a-b. A mixture
of I a-b (0.03 mole) was refluxed in acetic
anhydride (lOmL) and zinc dust (0.2g) for 10 hr.
The reaction mixture was left to cool and then
treated with cold water while stirring. The solid so
obtained was filtered and crystallized from the
suitable solvent to yield compounds 2a-b (cf.
Table I). Compounds 2a and 2b did not give colour
reaction with aq. ferric chloride solution.
2a: IR (KBr) 1657(C=O of y-pyrone),
1621(C=O).
2b: IR (KBr) 1659(C=O of y-pyrone),
1632(C=O); PMR (CDCI3):2.35 (s, 3H, CH3), 3.39
(s, 3H, CaCH3), 3.91 (S, 3H, OCH3), 4.08 (s, 3H,
OCH3), 7.15 (d, J=2.5 Hz, IH, H-3 of furan) and
8.07 (d, J = 2.5Hz, IH, H-2 of furan).
Preparation of derivatives of II-methoxy-4,5-
dimethyl-2H-oxo-furo [3,2-g] (I] benzopyran
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Table I-Analytical and physical data of compounds
Compd. m.p. Yield Mol. formula Found(Ca1cd) %
(DC) (%) (Mol.wt.) C H N S X
2a 120-21 65" CISHI20s 66.2 4.1
(272.25) (66.17 4.40 -)
2b 159-60 801 C16H1406 63.7 4.6
(302.21) (63.58 4.63 -)
3a 180-81 50m CISH1204NZ 67.6 4.0 8.8
(320.21) (67.52 3.75 8.75 -)
3b 209-210 701 CI91HI40sNz 65.0 4.0 8.1
(412.27) (65.16 3.99 7.99 -)
3e 190-91 60m C,.HI2O)NZS 64.3 3.7 8.4 9.0
(336.27) (64.29 3.75 8.33 9.53 -)
3d 220-21 651 CI9HI40zNzS 62.0 4.0 7.7 9.0
(366.28) (62.30 3.82 7.65 8.75 -)
3e 120-21 60· CI9HIS04N) 65.2 4.3 12.0
(349.23) (65.35 4.29 12.03 -)
3f 138-39 70" CwH,aOsNz 65.7 5.0 7.5
(366.23) (65.59 4.91 7.65 -)
3g 205-206 751 C11HzoOsNz 63.7 5.1 6.9
(396.24) (63.66 5.05 7.07 -)
3b 135-36 55P C'SH,)O)N) 67.9 4.0 13.0
(319.22) (67.73 4.07 13.16 -)
Sa 150-51 651 C,sHIIOsBr 51.0 3.0 22.8
(351.06) (51.32 3.13 22.76)
Sb 177-78 . 70" CI6HI)06Br 50.5 3.5 21.0
(381.07) (50.43 3.41 22.76)
6a 180-81 75m CI6HIZ04NzS 58.8 3.8 8.7 10.0
(328.25) (58.55 3.66 8.53 9.77 -)
6b 14()-41 6()P C17HI4OsNS 57.0 4.0 8.0 9.1
(358.26) (56.99 3.91 7.82 8.95 -)
7a 220 501 C2)HI604N1S 66.6 4.0 6.9 8.0
(416.32) (66.36 3.84 6.73 7.70 -)
7b 190-91 651 C14HlaOsNzS 64.8 4.2 6.0 7.0
(446.33) (64.59 4.03 6.28 7.18 -)
7e 220 501 ClsHzI04N)S 65.5 4.8 9.0 7.0
(459.35) (65.37 4.57 9.15 6.98 -)
7d 200-201 50m CZ6Hl)OsN)S 64.0 4.8 8.7 6.8
(489.36) (63.82 4.70 8.59 6.55 -)
7e 130-31 75- C14H170sN2SCI 60.0 3.7 6.0 6.5 7.0
(480.79) (59.96 3.53 5.83 6.67 7.37)
S. 179-80 75m CuH170sN 70.2 4.3 3.6
(375.25) (70.42 4.53 3.73 -)
Sb 220-21 501 C2)H1906N 68.0 4.8 3.6
(405.26) 68.17 4.69 3.46 -)
Se 110-11 60· C22HI707N 65.05 4.0 3.6
(440.24) (64.89 4.17 3.44 -)
Sd 139-40 551 C13HI9O.N 63.0 4.5 3.4
(437.25) (63.18) 4.35 3.20 -)
Se 199-200 70m C13H2I06N 68.0 5.2 3.5
(407.25) (67.83 5.16 3.52 -)
Sf 110-11 50· CI9HI906N 63.8 5.0 4.0
(357.21) (63.89 5.32 3.92 -)
Sg 145-46 40" . C1Ji1lO7N 62.0 5.6 3.4
(387.22) (62.04 5.42 3.62 -)
Solvent: m = methanol, t = ethanol; n = n-Iiexane
p = pet. ether (80-11O°C);u = pet. ether (40-60°C)
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[3,4-e] pyridine-l-earbonitrile 3a: Compounds
3a-h and 4a-b. To a solution of 2a-b (0.03 mole)
in ethanol 30mL was added cyanoacetamide (0.03
mole), a-cyanothioacetamide, malononitrile or
ethyl cyanoacetate (0.03 mole) in the presence of
ammonium acetate (0.01 mole). The reaction
mixture was refluxed for 8 hr and the hot solution
was filtered. The solvents were removed under
reduced pressure, and the residue was crystallized
from appropriate solvent (cf. Table I).
All compounds did not give colour reaction with
aq. ferric chloride solution.
3b: IR(KBr):2223(C=N), 1700(C=0 of
pyridone), 1602 (C=N); MS: m1z 350 (M+, 31%).
The IR spectra of 3e-f showed absorption bands at
3329-3399 and 2206-2220 cm' for NH and C=N
respectively.
PMR (CDCI3) of3f: 2.96(s, 6H, 2xCH3), 3.8(s, 6H,
2xOCH3), 7.25(d., J=2.2 Hz, IH, H-3 of furan),
MS: m1z 349 (M+, 19%).
3h:IR(KBr), 3313 (NH), 1777 (C=O of ester),
1614 (C=N); PMR (DMSO-d6): 1.32(t,.l=7.1 Hz,
3H, CH3 of COOCH2CH3), 2.39 (s, 3H, OCH3),
3.45 (s, 3H, CH3), 4.05 (s, 3H, OCH3), 4.15 (s, 3H,
OCH3), 4.37 (q, J=7.1 Hz, 2H, CH2 of
COOCHzCH3), 5.02 (broad s, IH, NH,
exchangeable with DzO), 7.01 (d, J=2.5 Hz, 1H, H-
3 offuran) and 7.62 (d, J=2.5H, IH, H-2 offuran).
6-(O-bromoaeetyl-4-metboxy- and 4,9-dime-
thoxy-7-methyl-SH-furo[3,2-y] [1] benzopyran-
S-one Sa-b.To a solution of 2a-b (0.008 mole) was
added chloroform (lOmL) while shaking for half
an hour. The solid so obtained was filtered and
crystallized from a suitable solvent to give Sa-b
which gave no colour reaction with aq. ferric
chloride solution (cf. Table I).
The IR spectra of Sa and Sb showed absorption
bands at 1694 and 1688 cm " (C=O of COCH2Br),
1657 and 1659 for (C=O ofy-pyrone) and 798 and
797 (C-Br).
PMR of Sa (DMSO-d6): 2.01 (s, 3H, CH3), 4.16
(s, 3H, OCll3), 5.4 (s, 2H, COCHzBr), 7.02 (d,
J=2.2 Hz, IH, H-3 of furan), 7.4 (s, IH,
benzofuran) and 7.59 (d, J=2.2 Hz, IH, H-2 of
furan).
2-amino-4-( 4-methoxy-7 -methyl-SH-furo [3,2-
g) [1] benzopyranyl) thiazoles 6 a-b. When a
suspension of 5a-b (0.008 mole) in hot ethanol
(15mL) was treated with thiourea (0.02 mole), a
smooth exothermic reaction took place giving a
clear solution that soon deposited crystals. The
crystals were filtered, washed with ethanol and
then boiled with water containing sodium acetate.
The bright yellow crystals were crystallized from a
suitable solvent to yield 6a-b (cf. Table I).
6a: IR (KBr) : 3256 and 3202 ern" (NHz), 1656
(C=O of y-pyrone) and 1603 cm " (C=N); MS
(m1z) : 328 (M+, 48%), 329 (M+ + 1, 27%),
313(M+-NHz), 213 (M+ - C3HNS, 51%).
2-imino-4-( 4-methoxy-7 -methyl-SH-furo [3,2-
g) [1] benzopyranyl) thiazoles 7a-d. To a solution
of 6a-b (0.03 mole) in ethanol (30mL) was added
aldehyde (0.03 mole) (i.e. benzaldehyde, 4-
chlorobenzaldehyde or p-N,N-dimethylamino-
benzaldehyde) in the presence of ammonium
acetate (0.01 mole). The reaction mixture was
refluxed for 8hr, filtered and crystallized from the
appropriate solvent to give 7a-d (cf. Table I).
7e: PMR (CDCl/TMS): 2.3 (s, 3H, Cll3), 4.05
(s, 3H, OCH3), 4.35 (s, 3H, OCH3), 6.5 (d, J=2.5
Hz, lH, H-3 of furan) , 6.9 (s, IH, = CH ofthiole),
7.2 (d, J= 8.5 Hz, 2H, phenyl), 7.7-7.9 (m, 3H, 2H
of phenyl and IH ofH-2 of furan) , and 8.5 (s, IH,
N=CH); MS: m1z 481 (M+, 39%).
6-(O-aminoacetyl-4-metboxy-7-methyl-SH-
furo-3,2-g] [1]benzopyrany-S-one 8 a-g. A
solution of .sa-b (0.03 mole) and the appropriate
amine (0.05 mole) (i.e. benzylamine, 4-
aminobenzoic acid, 4-toluidine or morpho line ) in
ethanol (30 rnL) was refluxed for 2hr, cooled and
the solid separated was crystallized from the
suitable solvent to furnish 8a-g (cf. Table I). All
compounds gave no colour reaction with aq. ferric
chloride solution.
8e: IR (KBr): 3214 (NH), 1663 (C=O of y-
pyrone), 1644 (C=O), 2750-3250 cm' (br, OH of
COOH).
PMR (CDCI3) : 217 (s, 3H, CH3), 4.22 (s, 3H,
OCH3), 4.72 (s, 2H, COCH2), 6.9 (d, J=2.4 Hz, IH,
H-3 of furan), 7.4 (d, J=8.7 Hz, 2H, aromatic), 7.5
(s, IH, benzofuran), 7.7 (d, J=2.4 Hz, IH, H-2 of
furan) , 8.45 (d, J=8.7 Hz, 2H, aromatic) and 13.18
(br, 1H, OH, exchangeable with DzO); MS: m1z of
8d at 437 (1f, 55%).
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